Molecular regulation of native hematopoiesis

天然造血的分子调控

基本信息

  • 批准号:
    10541825
  • 负责人:
  • 金额:
    $ 71.41万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2016
  • 资助国家:
    美国
  • 起止时间:
    2016-02-15 至 2024-12-31
  • 项目状态:
    已结题

项目摘要

SUMMARY Decades of work have established a paradigm for hematopoietic regeneration and maintenance based on the activity of multipotent hematopoietic stem cells (HSCs) at its apex. Our understanding of the fundamental properties of HSCs and progenitor populations has been historically based on notions derived from transplantation assays. Data over the last few years, however, have challenged the most fundamental aspects of models based on these studies, and have raised biological questions that are of direct clinical relevance in the hematology field. Additionally, it is now clear that intrinsic heterogeneity exists among seemingly pure populations of HSCs and downstream progenitors. How the functionally distinct behavior of these stem/progenitor cells is molecularly regulated and how individual clone size is controlled over time represent important biological questions relevant to our understanding of normal and diseased hematopoiesis. Over the past five years, my lab has developed novel single cell-based lineage tracing systems to study hematopoietic biology in the non-transplanted individual, which we refer to as native hematopoiesis. With these tools, we have shown that important biological differences exist between the source of hematopoietic cells and their outcomes when comparing transplantation versus native blood physiology. More recently, we have coupled lineage output readouts with molecular measurements at the single cell level, allowing us to identify transcriptional features of stem/progenitor cells that carry distinct functional outcomes. In this renewal application, we aim to utilize these high-resolution lineage-tracing tools to further characterize drivers of functional HSC heterogeneity and aging in native hematopoiesis. First, we will functionally and molecularly characterize a novel transcriptional regulator of the native HSC state, which we have identified using our singe cell screens. Second, we will utilize a combination of single cell lineage tracing, transcriptomics, and epigenomics to understand the molecular changes and clonal fluctuations that occur during the aging process in the mouse. Third, we will adapt our single cell molecular tracing strategies to characterize human hematopoiesis in a surrogate native state, and to identify potential novel regulators of human HSC behavior. Our comprehensive and interdisciplinary studies will shed led on the cellular and molecular mechanisms driving hematopoiesis in situ. Moreover, these studies will inform efforts to enhance hematopoietic regeneration and prevent pre-malignant clonal hematopoiesis.
总结 几十年的工作已经建立了一个基于造血干细胞的再生和维持的范例。 多能造血干细胞(HSC)在其顶端的活性。我们对基本的理解 HSC和祖细胞群体的特性在历史上一直基于来自以下的概念: 移植试验然而,过去几年的数据对最基本的方面提出了挑战。 基于这些研究的模型,并提出了与临床直接相关的生物学问题, 血液学领域此外,现在很清楚,内在的异质性存在于看似纯 HSC和下游祖细胞的群体。这些功能上不同的行为 干/祖细胞是分子调节的,个体克隆大小如何随时间控制代表了 重要的生物学问题有关我们的理解正常和患病的造血。来 在过去的五年里,我的实验室开发了新的基于单细胞的谱系追踪系统来研究造血 非移植个体的生物学,我们称之为天然造血。有了这些工具,我们 已经表明,重要的生物学差异存在于造血细胞的来源和它们的来源之间。 比较移植与自体血液生理学的结果。最近,我们将 谱系输出读数与单细胞水平的分子测量,使我们能够识别 干/祖细胞的转录特征携带不同的功能结果。在这次更新中, 应用程序,我们的目标是利用这些高分辨率的谱系追踪工具,以进一步表征驱动程序, 功能性HSC异质性和天然造血中的老化。首先,我们将在功能上和 分子特征的天然HSC状态,我们已经确定了一种新的转录调节因子 使用我们的单细胞屏幕。第二,我们将利用单细胞谱系追踪, 转录组学和表观基因组学,以了解发生的分子变化和克隆波动 在老鼠的衰老过程中。第三,我们将调整我们的单细胞分子追踪策略, 表征在替代天然状态下的人造血,并鉴定潜在的新的造血调节因子。 人类HSC行为我们的综合性和跨学科的研究将在细胞和 原位造血的分子机制此外,这些研究将为加强 造血再生和防止癌前克隆性造血。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Fernando Camargo其他文献

Fernando Camargo的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Fernando Camargo', 18)}}的其他基金

High resolution lineage tracing of developmental hematopoiesis
发育造血的高分辨率谱系追踪
  • 批准号:
    10585400
  • 财政年份:
    2023
  • 资助金额:
    $ 71.41万
  • 项目类别:
Generation of a temporal, spatial, and molecular map of in situ hematopoiesis
生成原位造血的时间、空间和分子图
  • 批准号:
    10415468
  • 财政年份:
    2022
  • 资助金额:
    $ 71.41万
  • 项目类别:
Image guided profiling of the native HSC niche
原生 HSC 利基的图像引导分析
  • 批准号:
    10018892
  • 财政年份:
    2019
  • 资助金额:
    $ 71.41万
  • 项目类别:
Image guided profiling of the native HSC niche
原生 HSC 利基的图像引导分析
  • 批准号:
    10212380
  • 财政年份:
    2019
  • 资助金额:
    $ 71.41万
  • 项目类别:
Project 1 - Molecular and cellular determinants of hematopoietic clonal expansion
项目 1 - 造血克隆扩增的分子和细胞决定因素
  • 批准号:
    10641540
  • 财政年份:
    2017
  • 资助金额:
    $ 71.41万
  • 项目类别:
Molecular regulation of native hematopoiesis
天然造血的分子调控
  • 批准号:
    10157107
  • 财政年份:
    2016
  • 资助金额:
    $ 71.41万
  • 项目类别:
Molecular regulation of native hematopoiesis
天然造血的分子调控
  • 批准号:
    10321680
  • 财政年份:
    2016
  • 资助金额:
    $ 71.41万
  • 项目类别:
Clonal analysis of hematopoietic stem and progenitor biology in situ
造血干细胞和祖细胞生物学原位克隆分析
  • 批准号:
    9225236
  • 财政年份:
    2016
  • 资助金额:
    $ 71.41万
  • 项目类别:
Clonal analysis of hematopoietic stem and progenitor biology in situ
造血干细胞和祖细胞生物学原位克隆分析
  • 批准号:
    9030319
  • 财政年份:
    2016
  • 资助金额:
    $ 71.41万
  • 项目类别:
Reprogramming of liver cell fate by Hippo signaling
通过 Hippo 信号重新编程肝细胞命运
  • 批准号:
    8676791
  • 财政年份:
    2013
  • 资助金额:
    $ 71.41万
  • 项目类别:

相似海外基金

Hormone therapy, age of menopause, previous parity, and APOE genotype affect cognition in aging humans.
激素治疗、绝经年龄、既往产次和 APOE 基因型会影响老年人的认知。
  • 批准号:
    495182
  • 财政年份:
    2023
  • 资助金额:
    $ 71.41万
  • 项目类别:
Investigating how alternative splicing processes affect cartilage biology from development to old age
研究选择性剪接过程如何影响从发育到老年的软骨生物学
  • 批准号:
    2601817
  • 财政年份:
    2021
  • 资助金额:
    $ 71.41万
  • 项目类别:
    Studentship
RAPID: Coronavirus Risk Communication: How Age and Communication Format Affect Risk Perception and Behaviors
RAPID:冠状病毒风险沟通:年龄和沟通方式如何影响风险认知和行为
  • 批准号:
    2029039
  • 财政年份:
    2020
  • 资助金额:
    $ 71.41万
  • 项目类别:
    Standard Grant
Neighborhood and Parent Variables Affect Low-Income Preschool Age Child Physical Activity
社区和家长变量影响低收入学龄前儿童的身体活动
  • 批准号:
    9888417
  • 财政年份:
    2019
  • 资助金额:
    $ 71.41万
  • 项目类别:
The affect of Age related hearing loss for cognitive function
年龄相关性听力损失对认知功能的影响
  • 批准号:
    17K11318
  • 财政年份:
    2017
  • 资助金额:
    $ 71.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
  • 批准号:
    9320090
  • 财政年份:
    2017
  • 资助金额:
    $ 71.41万
  • 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
  • 批准号:
    10166936
  • 财政年份:
    2017
  • 资助金额:
    $ 71.41万
  • 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
  • 批准号:
    9761593
  • 财政年份:
    2017
  • 资助金额:
    $ 71.41万
  • 项目类别:
How age dependent molecular changes in T follicular helper cells affect their function
滤泡辅助 T 细胞的年龄依赖性分子变化如何影响其功能
  • 批准号:
    BB/M50306X/1
  • 财政年份:
    2014
  • 资助金额:
    $ 71.41万
  • 项目类别:
    Training Grant
Inflamm-aging: What do we know about the effect of inflammation on HIV treatment and disease as we age, and how does this affect our search for a Cure?
炎症衰老:随着年龄的增长,我们对炎症对艾滋病毒治疗和疾病的影响了解多少?这对我们寻找治愈方法有何影响?
  • 批准号:
    288272
  • 财政年份:
    2013
  • 资助金额:
    $ 71.41万
  • 项目类别:
    Miscellaneous Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了